Squamous Cell Carcinoma of Esophagus Completed Phase 1 Trials for Elgemtumab (DB15430)

Also known as: ESOPHAGEAL SQUAMOUS CELL CARCINOMA / Oesophageal squamous cell carcinoma / Esophageal Squamous Cell Carcinomas / Esophageal squamous cell carcinoma stage unspecified / Oesophageal epidermoid carcinoma NOS / Esophageal epidermoid carcinoma NOS / Squamous cell carcinoma of oesophagus / Squamous cell carcinoma of esophagus NOS / Oesophageal squamous cell carcinoma NOS / Oesophageal squamous cell carcinoma stage unspecified

IndicationStatusPhase
DBCOND0031573 (Squamous Cell Carcinoma of Esophagus)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01598077A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric CancerTreatment
NCT01822613Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)Treatment